Insights - Yesterday, Essa (EPIX) announced another collaboration, this time with Bayer. The two companies will run a combination of Essa’s EPI-7386 with Bayer’s Nubeqa (darolutamide) in patients with … Continue Reading
Premium: Read NowInsights - Affimed had their business update call this morning to primarily discuss updates on AFM24 and a few other items. Below are notes. Licensed NK Cells from MD … Continue Reading
Premium: Read NowInsights - Affimed(AFMD) hosted a call after market today to discuss cbNK+AFM13 data presented at AACR. KOL from MD Anderson Dr. Katy Rezvani was also on the call. Below … Continue Reading
Premium: Read NowInsights - A look at pre-clinical data that Jounce and Essa presented at AACR this past weekend. Jounce (JNCE)Jounce has breached the $10/share level with a weak … Continue Reading
Premium: Read NowInsights - Affimed (AFMD) released initial clinical data from the AFM13 + MD Anderson combo study at AACR this morning and it looked great. Ultimately, this data validates AFMD … Continue Reading
Premium: Read NowInsights - The American Association for Cancer Research (AACR) annual meeting will be hosted this coming weekend (April 9-14). Below is data to look for that will … Continue Reading
Premium: Read NowInsights - 9Meters (NMTR) announced a $30M raise this morning, selling 30M shares at $1/share. After this deal, fully diluted share count is approximately 297M. At a … Continue Reading
Premium: Read Now
